Ambev SA

Análisis de la acción Ambev SA (ABEV)

$3.220

-0.010 (-0.31%)Al cierre

Loading chart…
Máximo
3.230
Apertura
3.150
Precio medio ponderado por volumen
3.20
Volumen
32.77M
Capitalización
32.92B
Mínimo
3.140
Importe
104.75M
EV/EBITDA, TTM
1.24

Ambev SA, formerly Inbev Participacoes Societarias SA, is a Brazil-based company engaged in the brewing sector. The Company produces, distributes and sells beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated (NANC) beverages across the Americas. The Company's activities are divided into three segments: Latin America North, including sell of beer, CSD and NANC drinks in Brazil, as well as operations in the Dominican Republic, Saint Vincent, Antigua, Dominica, Cuba, Guatemala, El Salvador, Honduras, Nicaragua, Barbados and Panama; Latin America South, distributing products in Argentina, Bolivia, Paraguay, Uruguay, Chile; and Canada, represented by Labatt’s operations, which comprises sales in Canada and some exports to the U.S. market. The Company markets products under various brand names, such as Adriatica, Brahma, Leffe, Budweiser, Corona, PepsiCo and Lipton. It is a subsidiary of Interbrew International BV.

www.ambev.com.br

Análisis de IA of Ambev SA (ABEV)

Comprar

Ambev SA is a good buy right now due to a current price of $3.19, a strong year-to-date change of +29.15%, and a low forward P/E of 13.23, which suggests potential for growth. The stock has also shown a recent 5-day change of +6.69%, indicating positive momentum. However, the main risk is the downgrade from BofA, which cites muted earnings momentum and a tough cost outlook for 2027.

Métricas de valoración

El PER previsto actual de Ambev SA (ABEV) es 13.23, frente a su media de 5 años de 15.02.

PER previsto

Valor razonable
Media 5A P/E
15.02
P/E actual
13.23
Sobrevalorada
18.08
Infravalorada
11.97

EV/EBITDA previsto

Infravalorado
Media 5A EV/EBITDA
6.60
EV/EBITDA actual
1.24
Sobrevalorada
9.31
Infravalorada
3.89

Precio/ventas previsto

Muy infravalorado
Media 5A P/S
2.20
P/S actual
0.52
Sobrevalorada
3.01
Infravalorada
1.38

Escenarios de precio de Alphio AI para ABEV

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%ABEV

$2.86

Precio del escenario

B

Base

Base · 50%ABEV

$2.53

Precio del escenario

B

Bajista

Bajista · 25%ABEV

$2.02

Precio del escenario

Ballenas con ABEV en cartera

P

PPLA Participations Ltd.

+ Con en carteraABEV

+26.01%

Rentabilidad a 3 meses

S

Seafarer Capital Partners, LLC

+ Con en carteraABEV

+13.95%

Rentabilidad a 3 meses

C

Caixa Econômica Federal

+ Con en carteraABEV

+11.46%

Rentabilidad a 3 meses

G

GQG Partners, LLC

+ Con en carteraABEV

+5.93%

Rentabilidad a 3 meses

R

RWC Partners Limited

+ Con en carteraABEV

+3.68%

Rentabilidad a 3 meses

P

Pzena Investment Management, Inc.

+ Con en carteraABEV

+2.79%

Rentabilidad a 3 meses

Preguntas frecuentes sobre ABEV, respondidas por Alphio AI

Ambev SA, formerly Inbev Participacoes Societarias SA, is a Brazil-based company engaged in the brewing sector. The Company produces, distributes and sells beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated (NANC) beverages across the Americas. The Company's activities are divided into three segments: Latin America North, including sell of beer, CSD and NANC drinks in Brazil, as well as operations in the Dominican Republic, Saint Vincent, Antigua, Dominica, Cuba, Guatemala, El Salvador, Honduras, Nicaragua, Barbados and Panama; Latin America South, distributing products in Argentina, Bolivia, Paraguay, Uruguay, Chile; and Canada, represented by Labatt’s operations, which comprises sales in Canada and some exports to the U.S. market. The Company markets products under various brand names, such as Adriatica, Brahma, Leffe, Budweiser, Corona, PepsiCo and Lipton. It is a subsidiary of Interbrew International BV. It operates in the Consumer Non-Cyclicals sector.

Ambev SA is a good buy right now due to a current price of $3.19, a strong year-to-date change of +29.15%, and a low forward P/E of 13.23, which suggests potential for growth. The stock has also shown a recent 5-day change of +6.69%, indicating positive momentum. However, the main risk is the downgrade from BofA, which cites muted earnings momentum and a tough cost outlook for 2027.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar